Collect whole blood in a purple top (EDTA) tube.
Refrigerate sample until shipment. Send the sample at room temperature with overnight delivery for receipt Monday through Friday within 24 hours of collection.
Whole blood can be refrigerated until shipment.
Heparinized specimens, severely hemolyzed specimens, frozen, clotted or possibly commingled specimens, blood in non-sterile or leaky containers, mislabeled or inappropriately labeled specimens.
Do not heat, freeze or centrifuge blood before shipment. Refrigerate sample until shipment.
Mon - Fri 9:00am to 4:00pm
Classic Rett syndrome is a severe neurodevelopmental disorder that primarily affects females. While classic Rett syndrome is defined on the basis of strict diagnostic criteria, atypical forms of Rett do exist that vary in terms of age of onset (congenital and late regression variants) as well as symptom severity (preserved speech variant). In the congenital variant form, girls are floppy and retarded from the very first months of life. The majority of congenital variants do not bear MECP2 or CDKL5 mutations, with only four cases being reported with MECP2 mutations. Very recently, truncating mutations in the FOXG1 gene have been identified in these patients.
FOXG1 is located on 14q12. It encodes the forkhead box protein G1, FoxG1, a transcriptional factor with expression restricted to fetal and adult brain and testis. Truncating mutations have been identified in two patients with the congenital variant of Rett syndrome. Large deletions of the 14q12 region encompassing the FOXG1 gene as well as an inversion of the FOXG1 gene have also been described in some patients.
Large deletions and duplications will be detected using multiplex ligation-dependent probe amplification assay (MLPA).
Mutations in the FOXG1 have been identified in the congenital variant form of RTT syndrome. Overall, sequence and deletiona analysis will identify mutations in about 4% of RTT patients that are MECP2 and CDKL5 negative. The analytical sensitivity of this assay is 99%.
Sequence analysis of the FOXG1 gene is available.
Known mutation analysis of the FOXG1 gene is available to family members for mutations previously identified by sequence analysis or deletion/duplication analysis.
Prenatal testing is available to individuals who are confirmed carriers of mutations in the FOXG1 gene. Please contact the laboratory director to discuss appropriateness of testing prior to collecting a prenatal specimen.
Test results with interpretation will be mailed and/or faxed to the referring physician following completion of the test. Additional reports will be provided as requested.
The clinical utility of the assay is to support a clinical diagnosis of the disease, facilitate genetic counseling, assess the risk to other first degree relatives and to facilitate testing of at - risk family members.
Whole blood in EDTA purple top tubes is the preferred sample. High molecular weight genomic DNA, cheek epithelial cells, or other samples containing DNA may be acceptable. Contact the laboratory for specific instructions regarding such samples before sending the sample.